Clinical Trials
3 trialsNCT00012259 2021-06-10
Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
Takeda
Phase 2 Completed
NCT00104468 2008-01-17
Study of Troxatylâ„¢ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)
SGX Pharmaceuticals, Inc.
Phase 1/2 Terminated
NCT00129948 2006-11-03
Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
SGX Pharmaceuticals, Inc.
Phase 2 Terminated